Proprietary Formulation and Administration

Perceiva is a proprietary formulation of sirolimus for local ocular administration which provides sustained tissues levels, allowing higher ocular tissue concentrations and reduced treatment frequency.

This proprietary clear liquid formulation is easily administered through a minimally invasive subconjunctival injection as opposed to a traditional, invasive intravitreal injection. The simple subconjunctival injection provides key benefits such as:

• More Comfort for Patients
• More Convenience for Physicians
• Minimized Risk of Complications and Adverse Events

• Perceiva™
• Phase 1 Highlights
• Formulation & Administration

View an animated demonstration of the subconjunctival injection technique used in MacuSight's clinical trials

"Novel formulation, administered via subconjunctival injection, allows reduced administration frequency"